Search Results 551-560 of 17428 for SC

  1. Study Of The Safety, Tolerability, Pharmacokinetics And Biomarker Of DONQ52 In Celiac Disease Patients - Mayo Clinic

    Furthermore, to characterize the DONQ52 PK profile following single and multiple subcutaneous (SC) dose(s) in celiac disease patients and to investigate the ...

  2. Publications - Lauren F. Alexander, M.D. - Mayo Clinic

    ... SC, Expert Panel on Urologic Imaging:. ACR Appropriateness Criteria((R)) Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol ...

  3. Meet Our Residents - Plastic Surgery Integrated Residency (Minnesota) - Mayo Clinic College of Medicine & Science

    Jess Rames, M.D., M.E.. Hometown: Charleston, SC Undergraduate school: Clemson University Medical/graduate school: Duke for Medical Doctorate and Master of ...

  4. Publications - Adam T. Froemming, M.D. - Mayo Clinic

    ... SC, Foster BR, Froemming AT, Futterer JJ, Ganeshan DM, Gertner MR, Mankowski ... SC, Expert Panel on Urologic Imaging:. ACR Appropriateness Criteria((R)) ...

  5. Publications - Joaquin J. Garcia, M.D. - Mayo Clinic

    ... SC, Gamez ME, Rwigema JM, Holtzman AL, Price DL, Janus JR, Kasperbauer JL ... SC, Rwigema JCM, Chintakuntlawar AV, Savvides PS, Garcia JJ, Foote RL ...

  6. Ureteral injury malpractice compensation highest in cases of patient-perceived delays, inadequate workup and failure of supervision - Mayo Clinic

    B., Sc.D., M.P.H, and others, published in New England Journal of Medicine, found that 37% of claims for injury were not due to medical error. Therefore, it ...

  7. A Study To Evaluate ORIN1001 In Idiopathic Pulmonary Fibrosis Subjects - Mayo Clinic

    Aspirin < 81 mg/day, prophylactic subcutaneous (SC) heparin or SC low-molecular weight heparin for deep vein thrombosis prophylaxis or heparin flush to maintain ...

  8. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  9. Publications - Allison L. Ducharme-Smith, M.D. - Mayo Clinic

    McAvoy S, Ganapathiraju SC, Ducharme-Smith AL, Pritchett JR, Kosari F, Perez DS, Zhu Y, James CD, Smith DI. Non-random inactivation of large common fragile site ...

  10. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...